Effect of COVID-19 on transfusion availability
Prof. Dr. Andreas Buser (Basel, Switzerland)
Role of factor concentrates in surgical settings-US perspective
Prof. Dr. Kenichi Tanaka (Oklahoma, United States)
Alternatives to transfusion – the PBM approach
Prof. Dr. Dietmar Fries (Innsbruck, Austria)
The European Society of Anaesthesiology and Intensive Care (ESAIC)
The COVID-19 pandemic challenged healthcare systems around the world. One difficulty has been the reduction in the availability of blood and blood products that has been compensated partly by the cancellation of non-emergency surgical procedures. Hospitals using Point of Care-based blood management protocols involving coagulation factor concentrates appear to have been less affected than the ones still relying on traditional transfusion strategies. This demonstrates the value of Patient Blood Management and highlights why it should be more of a priority for hospitals.
This topic will be explored further in the Octapharma Scientific Symposium, Patient Blood Management Challenges during the COVID-19 Pandemic, which will be chaired by Prof Dr Dietmar Fries from Innsbruck, Austria, and will feature US and European perspectives on bleeding management during the pandemic.
Thanks to all attendees. The recording will be available shortly.